- Home
- BDSX vs SABA Comparison
BDSX vs SABA Comparison
Compare BDSX & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SABA
- Stock Information
- Founded
- BDSX 2005
- SABA 1988
- Country
- BDSX United States
- SABA United States
- Employees
- BDSX N/A
- SABA N/A
- Industry
- BDSX Precision Instruments
- SABA
- Sector
- BDSX Health Care
- SABA
- Exchange
- BDSX Nasdaq
- SABA Nasdaq
- Market Cap
- BDSX 115.4M
- SABA 260.0M
- IPO Year
- BDSX 2020
- SABA N/A
- Fundamental
- Price
- BDSX $0.30
- SABA $9.13
- Analyst Decision
- BDSX Strong Buy
- SABA
- Analyst Count
- BDSX 5
- SABA 0
- Target Price
- BDSX $1.75
- SABA N/A
- AVG Volume (30 Days)
- BDSX 1.0M
- SABA 290.0K
- Earning Date
- BDSX 08-06-2025
- SABA 01-01-0001
- Dividend Yield
- BDSX N/A
- SABA 12.91%
- EPS Growth
- BDSX N/A
- SABA N/A
- EPS
- BDSX N/A
- SABA N/A
- Revenue
- BDSX $74,463,000.00
- SABA N/A
- Revenue This Year
- BDSX $17.29
- SABA N/A
- Revenue Next Year
- BDSX $29.33
- SABA N/A
- P/E Ratio
- BDSX N/A
- SABA N/A
- Revenue Growth
- BDSX 35.76
- SABA N/A
- 52 Week Low
- BDSX $0.17
- SABA $3.64
- 52 Week High
- BDSX $2.04
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- BDSX 51.06
- SABA 64.47
- Support Level
- BDSX $0.27
- SABA $9.08
- Resistance Level
- BDSX $0.31
- SABA $9.29
- Average True Range (ATR)
- BDSX 0.02
- SABA 0.11
- MACD
- BDSX 0.01
- SABA -0.00
- Stochastic Oscillator
- BDSX 79.26
- SABA 69.70
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.